Downstream Processing Featured Articles

1. Sanofi And PATH Announce The Launch Of Large-Scale Production Of Semisynthetic Artemisinin Against Malaria 4/12/2013

   Sanofi (Euronext: SAN and NYSE: SNY) and PATH’s Drug Development program, established through an affiliation with OneWorld Health, today announced the launch of the large-scale production line of semisynthetic artemisinin at Sanofi’s Garessio site in Italy.

2. Unraveling The Molecular Roots Of Down Syndrome 3/24/2013

   What is it about the extra chromosome inherited in Down syndrome—chromosome 21—that alters brain and body development? Researchers have new evidence that points to a protein called sorting nexin 27, or SNX27.

3. GE Healthcare Launches FF High Performance Nitrocellulose Membranes Optimized For Diagnostic Assay Reproducibility 8/1/2012

   GE Healthcare Life Sciences’ new Whatman FF High Performance (HP) membrane provides the industry with a new diagnostic membrane to enable fast, razor-sharp line separation and highly reproducible results for the detection of target molecules in liquids such as water, urine, blood and saliva.

4. Paired Genes In Stem Cells Shed New Light On Gene Organization And Regulation 2/4/2013

   Whitehead Institute researchers have determined that DNA transcription, the process that produces messenger RNA (mRNA) templates used in protein production, also runs in the opposite direction along the DNA to create corresponding long noncoding RNAs (lncRNAs). By Nicole Giese Rura

5. MMRGlobal Targets Phase 3 Biotech Companies To Combine Assets With Life Sciences Group 11/19/2012

   MMRGlobal, Inc. (OTCBB: MMRF) today announced that through its wholly owned subsidiary, MMR Life Sciences Group, the Company plans on exploiting its pipeline of biotech assets by facilitating a partnership or other joint venture with a privately held biotech company that has completed its Phase 2 clinical trials and is in the process of beginning Phase 3.

6. Mayo Clinic Uses New Approach To Reverse Multiple Sclerosis In Mice Models 6/28/2012

   Mayo Clinic researchers have successfully used smaller, folded DNA molecules to stimulate regeneration and repair of nerve coatings in mice that mimic multiple sclerosis (MS). They say the finding, published today in the journal PLoS ONE, suggests new possible therapies for MS patients.

7. Putting Capillary Electrophoresis to Work 3/8/1999
   It's been over 10 years since the first commercial instrument for capillary electrophoresis (CE) was introduced with a fanfare and a list of promises to revolutionize the world of separation science...
8. New Monoclonal Antibody Developed That Can Target Proteins Inside Cancer Cells 3/13/2013

   Researchers have discovered a unique monoclonal antibody that can effectively reach inside a cancer cell, a key goal for these important anticancer agents, since most proteins that cause cancer or are associated with cancer are buried inside cancer cells.

9. LEWA Uses A Globally Exclusive License To HPLC Technology From Bayer Technology Services 6/12/2012

   Bayer Technology Services (BTS) is a well-known supplier of industrial chromatography products and services in the area of process technologies for the Bayer Group and for external customers. 

10. New 'Binary Technology' Boosts Plasmid DNA Purification Efficiency and Throughput 11/7/2001
    The Aurum™ family of plasmid DNA purification systems is designed to significantly increase speed and consistency, from the highest-throughput 96-well applications through small-scale column studies.